Ravi Mehrotra
Overview
Explore the profile of Ravi Mehrotra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
229
Citations
5420
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Onwordi E, Whitehurst T, Shatalina E, Carr R, Mansur A, Arumuham A, et al.
Transl Psychiatry
. 2025 Mar;
15(1):70.
PMID: 40025026
Loss of glutamatergic terminals is hypothesised to contribute to excitation-inhibition imbalance in schizophrenia, supported by evidence that the normal positive association between glutamate concentrations and synaptic terminal density is not...
2.
Mehrotra R, Lauby-Secretan B
Oral Dis
. 2025 Feb;
PMID: 39928051
Objective: This review presents an overview of the current knowledge on smokeless tobacco and oral cancer, with a specific focus on South and Southeast Asia. Method: The recent literature on...
3.
Saini K, Somara S, Ko H, Thatai P, Quintana A, Wallen Z, et al.
Front Oncol
. 2024 Oct;
14:1473706.
PMID: 39439946
Recent strides in understanding the molecular underpinnings of head and neck cancers have sparked considerable interest in identifying precise biomarkers that can enhance prognostication and enable personalized treatment strategies. Immunotherapy...
4.
Rahman M, Rahman M, Islam M, Gilmour S, Haruyama R, Budukh A, et al.
J Epidemiol
. 2024 Sep;
35(3):129-140.
PMID: 39245580
Background: The burden of cancer in India has been rising, yet testing for early detection remains low. This study explored inequalities in the uptake of breast cancer (BC) examination and...
5.
Saini H, Basu P, Nesari T, Huddar V, Ray K, Srivastava A, et al.
Am J Transl Res
. 2024 Jun;
16(5):1499-1520.
PMID: 38883353
Breast cancer (BC) ranks number one among cancers affecting women globally. Serious concerns include delayed diagnosis, poor prognosis, and adverse side effects of conventional treatment, leading to residual morbidity. Therefore,...
6.
Coyle K, Singh P, Kaushik R, Huque R, Khan Z, Mehrotra R, et al.
Nicotine Tob Res
. 2024 May;
PMID: 38715337
Introduction: Under the current policy landscapes, the lifetime health and economic burden of smokeless tobacco (ST) products, consumed by over 297 million ST users in South Asia, is unknown. The...
7.
Centeno B, Saieg M, Siddiqui M, Perez-Machado M, Layfield L, Weynand B, et al.
Cancer Cytopathol
. 2024 May;
132(7):396-418.
PMID: 38709670
The recently published WHO Reporting System for Pancreaticobiliary Cytopathology (World Health Organization [WHO] System) is an international approach to the standardized reporting of pancreaticobiliary cytopathology, updating the Papanicolaou Society of...
8.
Jahangir C, Page D, Broeckx G, Gonzalez C, Burke C, Murphy C, et al.
J Pathol
. 2024 Jan;
262(3):271-288.
PMID: 38230434
Recent advances in the field of immuno-oncology have brought transformative changes in the management of cancer patients. The immune profile of tumours has been found to have key value in...
9.
Ong S, Haruyama R, Yip C, Ngan T, Li J, Lai D, et al.
EClinicalMedicine
. 2023 Dec;
67:102365.
PMID: 38125964
Background: The Global Breast Cancer Initiative (GBCI) Framework, launched by the World Health Organisation (WHO) in 2023, emphasises assessing, strengthening, and scaling up services for the early detection and management...
10.
Stanfill S, Hecht S, Joerger A, Gonzalez P, Maia L, Rivas M, et al.
Crit Rev Toxicol
. 2023 Dec;
53(10):658-701.
PMID: 38050998
Tobacco use is a major cause of preventable morbidity and mortality globally. Tobacco products, including smokeless tobacco (ST), generally contain tobacco-specific -nitrosamines (TSNAs), such as '-nitrosonornicotine (NNN) and 4-(methylnitrosamino)-1-(3-pyridyl)-butanone (NNK),...